Literature DB >> 33627186

The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report.

Alka Mishra1, Sumitra A Bentur2, Sonika Thakral3,4, Rahul Garg5,6,7, Bhanu Duggal8.   

Abstract

BACKGROUND: We report a high-risk case of a coronavirus disease 19 (COVID-19)-positive patient with comorbidities including diabetes mellitus (DM), hypertension (HTN), hypothyroidism and chronic kidney disease (CKD), treated successfully using an integrative therapy plan based on Ayurveda and Yoga, along with government-mandated compulsory modern western medicine (MWM) treatment. Recently, some evidence has been emerging on the use of Ayurveda for treatment of COVID-19. The classical texts of Ayurvedic medicine such as Charaka Samhita and Sushruta Samhita contain descriptions of pandemics of similar proportions and describe them as Janapadoddhvansa, meaning the destruction of communities, along with their causes and treatment. CASE
PRESENTATION: The case reported herein is a 55-year-old man from Delhi, India, with confirmed (tested) COVID-19, who first took MWM for 7 days before seeking integrative therapy. The patient has comorbidities including DM, HTN, hypothyroidism and CKD and had developed symptoms including fever (which was resolved by the time integrative therapy was started), sore throat, dry cough, body aches, weakness, bad taste and smell, and heaviness in the abdomen. Based on the patient's symptoms and comorbidities, a treatment plan including Ayurvedic medicines, Yoga protocol, dietary recommendations and lifestyle modifications was prescribed by a registered Ayurveda doctor and a Yoga consultant. The patient started experiencing improvement in all the symptoms within 2 days after starting the treatment; he reported approximately [Formula: see text] relief from the symptoms after 5 days, and almost complete relief within 9 days. Also, the blood sugar levels (both fasting blood sugar [FBS] and postprandial blood sugar [PPBS]) exhibited significant improvement after 5 days, and decreased to within the normal range within 12 days. Besides relief in symptoms, the patient's real-time reverse transcription polymerase chain reaction (RT-PCR) test done on the 19th day returned negative results.
CONCLUSIONS: Integrative therapy was found to be effective in mitigating the symptoms of COVID-19 in this patient with multiple comorbidities. Moreover, a significant improvement in blood sugar levels (not under control with modern medicine) was also achieved. Integrative therapy based on the classical texts of Ayurveda and Yoga may offer a promising and scalable treatment option for COVID-19 patients. A case series or a suitably designed randomized controlled trial is needed to assess its efficacy.

Entities:  

Keywords:  Ayurveda; COVID-19; Case report; Integrative therapy; Yoga

Year:  2021        PMID: 33627186     DOI: 10.1186/s13256-020-02624-1

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  37 in total

1.  Double-blinded randomized controlled trial for immunomodulatory effects of Tulsi (Ocimum sanctum Linn.) leaf extract on healthy volunteers.

Authors:  Shankar Mondal; Saurabh Varma; Vishwa Deepak Bamola; Satya Narayan Naik; Bijay Ranjan Mirdha; Madan Mohan Padhi; Nalin Mehta; Sushil Chandra Mahapatra
Journal:  J Ethnopharmacol       Date:  2011-05-17       Impact factor: 4.360

Review 2.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

Review 3.  The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature.

Authors:  Negar Jamshidi; Marc M Cohen
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-16       Impact factor: 2.629

4.  Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis.

Authors:  Omar Ariel Espinosa; Andernice Dos Santos Zanetti; Ednardo Fornanciari Antunes; Fabiana Gulin Longhi; Tatiane Amorim de Matos; Paula Franciene Battaglini
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-06-22       Impact factor: 1.846

5.  Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.

Authors:  Lihua Zhu; Zhi-Gang She; Xu Cheng; Juan-Juan Qin; Xiao-Jing Zhang; Jingjing Cai; Fang Lei; Haitao Wang; Jing Xie; Wenxin Wang; Haomiao Li; Peng Zhang; Xiaohui Song; Xi Chen; Mei Xiang; Chaozheng Zhang; Liangjie Bai; Da Xiang; Ming-Ming Chen; Yanqiong Liu; Youqin Yan; Mingyu Liu; Weiming Mao; Jinjing Zou; Liming Liu; Guohua Chen; Pengcheng Luo; Bing Xiao; Changjiang Zhang; Zixiong Zhang; Zhigang Lu; Junhai Wang; Haofeng Lu; Xigang Xia; Daihong Wang; Xiaofeng Liao; Gang Peng; Ping Ye; Jun Yang; Yufeng Yuan; Xiaodong Huang; Jiao Guo; Bing-Hong Zhang; Hongliang Li
Journal:  Cell Metab       Date:  2020-05-01       Impact factor: 27.287

Review 6.  COVID-19: Environment concern and impact of Indian medicinal system.

Authors:  Vijay Kumar; Shyam Babu Singh; Simranjeet Singh
Journal:  J Environ Chem Eng       Date:  2020-06-06

7.  Virtual repurposing of ursodeoxycholate and chenodeoxycholate as lead candidates against SARS-Cov2-Envelope protein: A molecular dynamics investigation.

Authors:  Reena Yadav; Chinmayee Choudhury; Yashwant Kumar; Alka Bhatia
Journal:  J Biomol Struct Dyn       Date:  2020-12-31       Impact factor: 5.235

8.  Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis.

Authors:  Bolin Wang; Ruobao Li; Zhong Lu; Yan Huang
Journal:  Aging (Albany NY)       Date:  2020-04-08       Impact factor: 5.682

Review 9.  Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning response meet.

Authors:  Ravi Philip Rajkumar
Journal:  Brain Behav Immun       Date:  2020-04-22       Impact factor: 7.217

10.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Yi Zhao; Heng-Rui Liang; Zi-Sheng Chen; Yi-Min Li; Xiao-Qing Liu; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Chun-Quan Ou; Li Li; Ping-Yan Chen; Ling Sang; Wei Wang; Jian-Fu Li; Cai-Chen Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zheng-Yi Ni; Jie Xiang; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

View more
  3 in total

Review 1.  Yoga and meditation, an essential tool to alleviate stress and enhance immunity to emerging infections: A perspective on the effect of COVID-19 pandemic on students.

Authors:  Nibedita Dalpati; Subhashree Jena; Shikha Jain; Pranita P Sarangi
Journal:  Brain Behav Immun Health       Date:  2022-01-19

2.  A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review.

Authors:  Melissa S Barber; Richard Barrett; Ryan D Bradley; Erin Walker
Journal:  Complement Ther Med       Date:  2021-11-06       Impact factor: 2.446

Review 3.  Yoga, Meditation, Breathing Exercises, and Inflammatory Biomarkers with Possible Implications in COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Komal Shah; Chiranjivi Adhikari; Shubham Sharma; Somen Saha; Deepak Saxena
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-07       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.